Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 11-2014 | 09-2014 | 08-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 580 | 580 | -2,170 | -2,170 | 1,230 |
| Depreciation Amortization | 1,560 | 1,560 | 1,070 | 1,070 | 1 |
| Other Working Capital | 1,490 | 1,490 | 1,670 | 1,670 | 1,090 |
| Other Operating Activity | -7,720 | -7,720 | -2,730 | -2,730 | -2,771 |
| Operating Cash Flow | $-4,090 | $-4,090 | $-2,160 | $-2,160 | $-450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -30 | -30 | -30 | 0 |
| Other Investing Activity | 5,060 | 5,060 | 1,460 | 1,460 | -7 |
| Investing Cash Flow | $5,030 | $5,030 | $1,430 | $1,430 | $-7 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 40 | 40 | 40 | 40 | 40 |
| Financing Cash Flow | $40 | $40 | $40 | $40 | $40 |
| Exchange Rate Effect | 40 | 40 | 3 | 3 | -5 |
| Beginning Cash Position | 600 | 600 | 620 | 620 | 610 |
| End Cash Position | 1,630 | 1,630 | -60 | -60 | 190 |
| Net Cash Flow | $1,030 | $1,030 | $-680 | $-680 | $-420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,090 | -4,090 | -2,160 | -2,160 | -450 |
| Free Cash Flow | -4,090 | -4,090 | -2,160 | -2,160 | -450 |